Predict your next investment

RISK & SECURITY | Security Products
certirx.com

See what CB Insights has to offer

Stage

Unattributed - II | Alive

Total Raised

$850K

Last Raised

$220K | 7 yrs ago

About CertiRx Corporation

CertiRx Corporation (CertiRx) is developing and commercializing platform technology for authentication and verification of high-value products and important documents. The Company's technology has broad applicability, including 1) identification of counterfeits, even where these have been separated from packaging; 2) more effective tracking of lost, damaged, stolen, or diverted goods, and 3) linking critical documents to their source data in secure digital systems.

CertiRx Corporation Headquarter Location

2 Davis Drive

Durham, North Carolina, 27709,

United States

919-323-9338

Latest CertiRx Corporation News

ACG Inspection Partners with Verinetics to Further Strengthen Their Fight Against Falsified Medicines

Aug 8, 2018

August 08, 2018 08:00 AM Eastern Daylight Time MUMBAI, India & RESEARCH TRIANGLE PARK, N.C.--( BUSINESS WIRE )-- ACG Inspection (ACGI) has partnered with CertiRx Corporation, d.b.a. “ Verinetics ” for further enhancing its Traceability and Authenticity solutions in the Track and Trace industry. With this partnership, ACG Inspections is looking forward to implementing an add-on security layer to provide Multi-Factor Authentication to the end consumer. Multi-factor authentication is a security system that requires more than one method of authentication from independent categories of credentials to verify an identity. Verinetics patent-protected software product, TraxSecur™ is a next-generation solution for detecting and deterring fraud in the supply chain. Using TraxSecur as a security mark provides intelligent authentication, linked with serialization data. This makes ACG Inspection an end to end solution provider for Track and Trace requirements, product tracing and authentication solutions. Falsified medications are one of the major problems faced by the global pharmaceutical industry. As per the World Health Organization (WHO), an estimated 1 in 10 medical products in low- and middle-income countries is substandard or falsified. This year, on World Anti-Counterfeiting Day (6th June 2018), ACG Inspection waged a war against falsified medicines. This campaign emphasized on the effects of substandard or falsified medicines on the human population and the global pharmaceutical industry with the message "Get the Fake Drugs Off the Market". On the association between ACG Inspection and Verinetics, Mr. Ettore Cucchetti , CEO, ACG Inspection said, “With the increasing threat of falsified medicines in the pharmaceutical supply chain and regulations mandating companies to deploy strategies such as serialization and to have greater awareness, there is a need for innovative and effective solutions for product authentication, Track and Trace and supply chain integrity. We strongly believe that our association with Verinetics is a step towards nipping the problem that is grappling the industry today. With the introduction of TraxSecur with Track and Trace regulatory compliance will help us to safeguard the existing supply chain. The association will equip consumers with product authentication and ensure genuine products to consumers. Also, it will bring the consumer closer to the pharmaceutical companies, providing first hand feedback about the products.” Dr. Tom Mercolino , CEO Verinetics said “Wherever high-value products have health and safety risks, companies are investing to protect their customers through supply chain security solutions like serialization and blockchain. ACGI has the vision to bring TraxSecur to the pharmaceutical market and deliver its unique benefits as a secure link between items in the physical world and data about those items being tracked in serialization and blockchain systems. We also applaud ACGI for recognizing the importance of TraxSecur’s multilayered approach for deterring supply chain frauds with overt feature, increasing fraud detection and enforcement effectiveness through it covert features, and how it’s implementation will increase patient trust in their customers’ products.” Contacts

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CertiRx Corporation Patents

CertiRx Corporation has filed 6 patents.

The 3 most popular patent topics include:

  • Block ciphers
  • Medical imaging
  • Infrared imaging
patents chart

Application Date

Grant Date

Title

Related Topics

Status

8/6/2018

6/2/2020

Block ciphers, Medical imaging, Antimalarial agents, Infrared imaging, Message authentication codes

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

8/6/2018

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

6/2/2020

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Block ciphers, Medical imaging, Antimalarial agents, Infrared imaging, Message authentication codes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.